BridgeBio Pharma
BBIO
$29.97
Share price
3.52%
Change (1 day)
101.95%
Change (1 year)
Categories
Earnings for BridgeBio Pharma (BBIO)
Earnings in 2023 (TTM): -$0.58 B
According to BridgeBio Pharma 's latest financial reports the company's current earnings (TTM) are -$0.47 B. In 2022 the company made an earning of -$0.41 B an increase over its 2021 earnings that were of -$0.54 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for BridgeBio Pharma from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.58 B | 41.5% |
| 2022 | -$0.41 B | -25.1% |
| 2021 | -$0.54 B | 15.11% |
| 2020 | -$0.47 B | 67.55% |
| 2019 | -$0.28 B | 67.65% |
| 2018 | -$0.17 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | -60.11% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -95.90% | 🇺🇸 USA |